Position history for BNP PARIBAS FINANCIAL MARKETS's holdings in APELLIS PHARMACEUTICALS INC
BNP PARIBAS FINANCIAL MARKETS holds 557,591 shares of APLS (APELLIS PHARMACEUTICALS INC), worth $14M as of 2025-Q4. The position was decreased (-42.7% shares). APLS represents 0.0% of BNP PARIBAS FINANCIAL MARKETS's portfolio.
Current Value
$14M
Current Shares
557,591
Total Value Change
+$10M
Total Shares Change
+453,173
Other major holders of APLS: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, BANQUE PICTET & CIE SA
Decreased |
| 557,591 |
-42.7% |
| $14M |
| 0.0% |
| $25.24 |
0 |
| 2025-Q3 | Decreased | 972,474 | -25.1% | $22M | 0.0% | $22.65 | 0 |
| 2025-Q2 | Increased | 1.3M | +16.9% | $22.5M | 0.0% | $17.43 | 33 |
| 2025-Q1 | Increased | 1.1M | +30.6% | $24.3M | 0.0% | $24.27 | 36 |
| 2024-Q4 | Increased | 850,823 | +432.8% | $27.1M | 0.0% | $31.90 | 46 |
| 2024-Q3 | Increased | 159,700 | +52.9% | $4.6M | 0.0% | $29.47 | 38 |
| 2024-Q2 | Increased | 104,418 | +102.3% | $4M | 0.0% | $38.36 | 43 |